 Effect tamoxifen serum insulinlike growth factor levels stage cancer patients Insulinlike growth factor IGF-I potent mitogen breast cancer cells vitro IGF-I receptors human primary breast neoplasms randomized placebo-controlled study administration antiestrogen tamoxifen patients breast cancer significant reduction serum level IGF-I mean IGF-I level U/mL placebo-treated group U/mL tamoxifen-treated group serum IGF-I level growth hormone GH dependent data pubertal surge GH IGF-I levels sex steroid dependent mechanism observation blockade tamoxifen estrogen action hypothalamic-pituitary axis tamoxifen treatment IGF-I levels reduction therapeutic effect drug